- Home
- LYEL vs UTMD Comparison
LYEL vs UTMD Comparison
Compare LYEL & UTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- UTMD
- Stock Information
- Founded
- LYEL 2018
- UTMD 1978
- Country
- LYEL United States
- UTMD United States
- Employees
- LYEL N/A
- UTMD N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- UTMD Medical/Dental Instruments
- Sector
- LYEL Health Care
- UTMD Health Care
- Exchange
- LYEL Nasdaq
- UTMD Nasdaq
- Market Cap
- LYEL 207.7M
- UTMD N/A
- IPO Year
- LYEL 2021
- UTMD N/A
- Fundamental
- Price
- LYEL $0.54
- UTMD $56.04
- Analyst Decision
- LYEL Sell
- UTMD
- Analyst Count
- LYEL 2
- UTMD 0
- Target Price
- LYEL $1.00
- UTMD N/A
- AVG Volume (30 Days)
- LYEL 866.3K
- UTMD 17.2K
- Earning Date
- LYEL 03-11-2025
- UTMD 04-24-2025
- Dividend Yield
- LYEL N/A
- UTMD 2.17%
- EPS Growth
- LYEL N/A
- UTMD N/A
- EPS
- LYEL N/A
- UTMD 3.96
- Revenue
- LYEL $61,000.00
- UTMD $40,903,000.00
- Revenue This Year
- LYEL N/A
- UTMD N/A
- Revenue Next Year
- LYEL N/A
- UTMD N/A
- P/E Ratio
- LYEL N/A
- UTMD $14.18
- Revenue Growth
- LYEL N/A
- UTMD N/A
- 52 Week Low
- LYEL $0.48
- UTMD $55.81
- 52 Week High
- LYEL $3.15
- UTMD $77.33
- Technical
- Relative Strength Index (RSI)
- LYEL 43.44
- UTMD 24.89
- Support Level
- LYEL $0.53
- UTMD $56.67
- Resistance Level
- LYEL $0.63
- UTMD $57.61
- Average True Range (ATR)
- LYEL 0.07
- UTMD 0.91
- MACD
- LYEL -0.00
- UTMD -0.05
- Stochastic Oscillator
- LYEL 26.39
- UTMD 7.87
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.